DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20164125

A survey on knowledge, attitude and practice of pharmacovigilance and adverse drug reaction reporting among healthcare professionals in a tertiary care hospital of Bihar, India

Pramod Kumar Manjhi, Manish Kumar, Harihar Dikshit, Lalit Mohan, Hitesh Mishra

Abstract


Background: This study was conducted to assess the knowledge, attitude and practice of pharmacovigilance (PV) and adverse drug reaction (ADR) reporting among healthcare professionals in a tertiary care hospital of Bihar.

Methods: It was a questionnaire based cross- sectional study carried out for a period of 3 months by a preformed structured questionnaire consisting of 19 questions (11 questions on knowledge, 5 on attitude and 3 on practices) in various departments of I.G.I.M.S., Patna. 120 filled questionnaires by healthcare professionals were collected from department and analysed for mentioned parameters. Among healthcare professionals there were 46 Interns, 20 junior and senior residents, 2 professors, 2 associate professors, 2 assistant professors, 48 nurses of the hospital. A descriptive analysis of data was done.

Results: Out of total 120 distributed questionnaires, 112 were completely filled up and considered for analysis. The response rate was 93.3%. Regarding knowledge, attitude and practice based questions 58.9% and 75% were knew the correct definition and important purpose of PV respectively. Among participants 62.5% have knowledge of post marketing surveillance studies done by Pharmaceutical companies and 79.4 % knew that within how many days serious adverse event (SAE) reported in India. Lack of time (36.6 %) followed by non- remuneration ( 33.3%) were major discouraging factor in ADR reporting. 36.6 % think reporting is a professional obligation for healthcare professionals and 19.6 % opined that ADR monitoring centre should be in every hospital. 89 % agree with necessity of ADR reporting where as 91% think PV should be taught in detail to healthcare professionals. 60.7 % had read an article on prevention of adverse drug reaction, 51.7 % had come across with an ADR and less than half (41.9 %) had been trained on how to report.

Conclusions: Findings strongly suggest that there is a great need to create awareness and to promote the reporting of ADR amongst prescribers since knowledge and awareness are the most important parameters that can minimize the under reporting of ADRs.


Keywords


Adverse drug reaction, Attitude and practice, Knowledge, Pharmacovigilance

Full Text:

PDF

References


World Health Organization. Safety of Medicines: A guide to detecting and reporting adverse drug reactions, Geneva, 2002.

International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972;498:1-25.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Journal of the American Medical Association, 1998; 279(15): 1200-1205.

Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. British Medical Journal. 2004;329(7456):15.

Oshikoya KA, Adverse drug reaction in children: types, incidence and risk factors. Nige Jou Pediat. 2006;33:29-35.

Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales- Olivas FJ, A prospective study of adverse drug reactions in hospitalized children. British Journal of Clinical Pharmacology. 1999;47:681-8.

Singh A, Bhatt P. comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form. Journal of Pharmacology and Pharmacotherapeutics. 2012;3(3):228-32.

Upadhyaya HB, Vora MB, Nagar JG, Patel PB. Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of tertiary care hospital in Gujarat. J Adv Pharm Technol Res. 2015;6(1):29-34.

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Underreporting of adverse drug reactions: A challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47:65-71.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2(4):129-36.

Chatterjee S, Lyle N, Ghosh S. A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Saf. 2006;29:641-2.

Oshikoya KA, Awobusuyi JO: Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.